Reduced-intensity unrelated cord blood transplantation for patients with advanced malignant lymphoma

Biology of Blood and Marrow Transplantation

Volumn 11, Issue 4, 2005, Pages 314-318

  Yuji, Koichiro ^a   Miyakoshi, Shigesaburo ^a   Kato, Daisuke ^a   Miura, Yuji ^a   Myojo, Tomohiro ^a   Murashige, Naoko ^b   Kishi, Yukiko ^b   Kobayashi, Kazuhiro ^c   Kusumi, Eiji ^a   Narimatsu, Hiroto ^a   Hamaki, Tamae ^b   Matsumura, Tomoko ^a   Kami, Masahiro ^b   Fukuda, Takahiro ^b   Masuo, Shigeru ^c   Masuoka, Kazuhiro ^a   Wake, Atsushi ^a   Ueyama, Junichi ^a   Yoneyama, Akiko ^a   Miyamoto, Ko ^d   Nagoshi, Haruhisa ^d   Matsuzaki, Michio ^a   Morinaga, Shinichi ^a   Muto, Yoshitomo ^a   Takeue, Yoichi ^b   Taniguchi, Shuichi ^a   more..

^a TORANOMON HOSPITAL   (Japan)

^b NATIONAL CANCER CENTER HOSPITAL   (Japan)

^c JR Tokyo General Hospital   (Japan)

^d ST MARIANNA UNIVERSITY   (Japan)

Author keywords

Cord blood transplantation; Non Hodgkin lymphoma; Reduced intensity stem cell transplantation

Indexed keywords

ACICLOVIR; ANTIBIOTIC AGENT; CYCLOSPORIN A; FLUCONAZOLE; FLUDARABINE; MELPHALAN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; SULFADOXINE; SULFAMETHOXAZOLE; TACROLIMUS;

ACUTE GRAFT VERSUS HOST DISEASE; ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER GROWTH; CANCER MORTALITY; CANCER RECURRENCE; CANCER SURVIVAL; CHRONIC GRAFT VERSUS HOST DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORD BLOOD STEM CELL TRANSPLANTATION; DRUG RESPONSE; FEASIBILITY STUDY; FEBRILE NEUTROPENIA; FEMALE; GRAFT FAILURE; HLA MATCHING; HUMAN; LYMPHOMA; MALE; PNEUMOCYSTOSIS; PRIMARY PREVENTION; PROBABILITY; REDUCED INTENSITY CONDITIONING; TREATMENT FAILURE; TREATMENT OUTCOME; WHOLE BODY RADIATION;

ADULT; AGED; CORD BLOOD STEM CELL TRANSPLANTATION; DISEASE-FREE SURVIVAL; FEMALE; GRAFT VS HOST DISEASE; HISTOCOMPATIBILITY TESTING; HUMANS; LYMPHOMA; MALE; MIDDLE AGED; RECURRENCE; TRANSPLANTATION CONDITIONING; WHOLE-BODY IRRADIATION;

EID: 20144389145     PISSN: 10838791     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbmt.2005.01.012     Document Type: Article

References (25)

1. R. Chopra A.H. Goldstone R. Pearce Autologous versus allogeneic bone marrow transplantation for non-Hodgkin's lymphoma: A case-controlled analysis of the European Bone Marrow Transplant Group Registry data J Clin Oncol 10 1992 1690-1695
2. L.F. Verdonck A.W. Dekker H.M. Lokhorst E.J. Petersen H.K. Nieuwenhuis Allogeneic versus autologous bone marrow transplantation for refractory and recurrent low-grade non-Hodgkin's lymphoma Blood 90 1997 4201-4205
3. I.F. Khouri M. Keating M. Korbling Transplant-lite: Induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies J Clin Oncol 16 1998 2817-2824
4. A.H. Goldstone P.D. Kottaridis The allogeneic effect in non-Hodgkin's lymphoma Leuk Lymphoma 44 suppl 3 2003 S91-S97
5. K. Branson R. Chopra P.D. Kottaridis Role of nonmyeloablative allogeneic stem-cell transplantation after failure of autologous transplantation in patients with lymphoproliferative malignancies J Clin Oncol 20 2002 4022-4031
6. T.E. Tanimoto E. Kusumi T. Hamaki High complete response rate after allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning regimens in advanced malignant lymphoma Bone Marrow Transplant 32 2003 131-137
7. I.F. Khouri R.M. Saliba S.A. Giralt Nonablative allogeneic hematopoietic transplantation as adoptive immunotherapy for indolent lymphoma: Low incidence of toxicity, acute graft-versus-host disease, and treatment-related mortality Blood 98 2001 3595-3599
8. K.E. Herbert A. Spencer A. Grigg G. Ryan C. McCormack H.M. Prince Graft-versus-lymphoma effect in refractory cutaneous T-cell lymphoma after reduced-intensity HLA-matched sibling allogeneic stem cell transplantation Bone Marrow Transplant 34 2004 521-525
9. N. Dhedin S. Giraudier P. Gaulard Allogeneic bone marrow transplantation in aggressive non-Hodgkin's lymphoma (excluding Burkitt and lymphoblastic lymphoma): A series of 73 patients from the SFGM database. Societ Francaise de Greffe de Moelle Br J Haematol 107 1999 154-161
10. M.J. Laughlin J. Barker B. Bambach et al. Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors N Engl J Med 344 2001 1815-1822
11. S. Miyakoshi K. Yuji M. Kami et al. Successful engraftment after reduced-intensity umbilical cord blood transplantation for adult patients with advanced hematological diseases Clin Cancer Res 10 2004 3586-3592
12. M.J. Laughlin M. Eapen P. Rubinstein et al. Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia N Engl J Med 351 2004 2265-2275
13. J.N. Barker D.J. Weisdorf T.E. DeFor B.R. Blazar J.S. Miller J.E. Wagner Rapid and complete donor chimerism in adult recipients of unrelated donor umbilical cord blood transplantation after reduced-intensity conditioning Blood 102 2003 1915-1919
14. D.A. Rizzieri G.D. Long J.J. Vredenburgh et al. Successful allogeneic engraftment of mismatched unrelated cord blood following a nonmyeloablative preparative regimen Blood 98 2001 3486-3488
15. J.A. Weinthal S.C. Goldman C. Lenarsky Successful treatment of relapsed Burkitt's lymphoma using unrelated cord blood transplantation as consolidation therapy Bone Marrow Transplant 25 2000 1311-1313
16. J. Ooi T. Iseki K. Ito et al. Successful unrelated cord blood transplantation for relapse after autologous transplantation in non-Hodgkin's lymphoma Leuk Lymphoma 43 2002 653-655
17. T. Yoshimasu A. Manabe R. Tanaka et al. Successful treatment of relapsed blastic natural killer cell lymphoma with unrelated cord blood transplantation Bone Marrow Transplant 30 2002 41-44
18. N.J. Chao L.P. Koh G.D. Long et al. Adult recipients of umbilical cord blood transplants after nonmyeloablative preparative regimens Biol Blood Marrow Transplant 10 2004 569-575
19. Pathlogy and Genetics: Tumors of Hematopoietic and Lymphoid Tissues 2001 World Health Organization Geneva
20. B.D. Cheson S.J. Horning B. Coiffier et al. Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas NCI Sponsored International Working Group J Clin Oncol 17 1999 1244
21. S.P. Robinson A.H. Goldstone S. Mackinnon et al. Chemoresistant or aggressive lymphoma predicts for a poor outcome following reduced-intensity allogeneic progenitor cell transplantation: An analysis from the Lymphoma Working Party of the European Group for Blood and Bone Marrow Transplantation Blood 100 2002 4310-4316
22. C.L. Toze M.J. Barnett J.M. Connors et al. Long-term disease-free survival of patients with advanced follicular lymphoma after allogeneic bone marrow transplantation Br J Haematol 127 2004 311-321
23. M.P. Escalon R.E. Champlin R.M. Saliba et al. Nonmyeloablative allogeneic hematopoietic transplantation: A promising salvage therapy for patients with non-Hodgkin's lymphoma whose disease has failed a prior autologous transplantation J Clin Oncol 22 2004 2419-2423
24. G.D. Long M. Laughlin B. Madan et al. Unrelated umbilical cord blood transplantation in adult patients Biol Blood Marrow Transplant 9 2003 772-780
25. A.K. Klein D.D. Patel M.E. Gooding et al. T-cell recovery in adults and children following umbilical cord blood transplantation Biol Blood Marrow Transplant 7 2001 454-466